Lexeo Therapeutics, Inc. Share Price
NASDAQ: LXEO | Micro CapLexeo Therapeutics, Inc. Stock Performance
Lexeo Therapeutics, Inc. Share Price Today
As of 30 October 2026, Lexeo Therapeutics, Inc.'s share price is $3.07. The stock opened at $3.19, compared to its previous close of $3.13. During today's trading session, Lexeo Therapeutics, Inc.'s share price traded between $3.05 and $3.37, with an average price of $3.21. Over the past 52 weeks, the stock has recorded a high of $10.97 and a low of $2.55. In terms of performance, Lexeo Therapeutics, Inc.'s share price has declined by 46.14% over the last six months and is down 69.36% on a year-on-year basis.
Lexeo Therapeutics, Inc. Share Price Chart
Lexeo Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Lexeo Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Lexeo Therapeutics, Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
Lexeo Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.35 | $3.08 | -8.35% |
Sep 2026 | $4.71 | $3.35 | -32.63% |
Aug 2026 | $4.05 | $4.98 | +20.73% |
Jul 2026 | $4.71 | $4.13 | -11.39% |
Jun 2026 | $5.00 | $4.66 | -9.44% |
May 2026 | $5.63 | $5.14 | -9.82% |
Apr 2026 | $6.01 | $5.70 | -0.52% |
Mar 2026 | $6.75 | $5.73 | -20.19% |
Feb 2026 | $7.42 | $7.18 | -4.01% |
Jan 2026 | $9.85 | $7.48 | -24.60% |
Dec 2025 | $9.81 | $9.92 | +0.66% |
Nov 2025 | $9.37 | $9.86 | -1.65% |